抗菌肽治疗糖尿病足溃疡的研究进展
Research Progress of Antimicrobial Peptides in the Treatment of Diabetic Foot Ulcers
DOI: 10.12677/hjbm.2025.153064, PDF,   
作者: 巨翡叶, 覃佐东：湖南工业大学生命科学与化学学院，湖南 株洲；湖南科技学院化学与生物工程学院，湖南 永州；聂立波*：湖南工业大学生命科学与化学学院，湖南 株洲；罗小芳：湖南科技学院化学与生物工程学院，湖南 永州
关键词: 抗菌肽；糖尿病足溃疡；组织修复；递送系统；Antimicrobial Peptides； Diabetic Foot Ulcers； Tissue Repair； Delivery Systems
摘要: 糖尿病足溃疡(DFU)是糖尿病严重的并发症，其慢性感染与组织修复障碍导致高截肢率及治疗成本攀升，给公共卫生体系带来了巨大临床挑战。抗菌肽(AMPs)因其多重抗菌机制及低耐药性风险使其成为治疗的新兴策略。现有研究表明，单一AMPs、联合疗法及相关递送系统均展现出显著疗效，尽管潜力显著，其具体分子机制、临床转化及长期安全性仍需深入探索。未来研究需聚焦于探索AMPs的分子作用机制、开发智能递送系统及大规模临床试验，以突破临床转化瓶颈。本文通过综述近年来国内外关于AMPs及相关治疗策略在促DFU修复中的最新研究进展，为AMPs作为治疗DFU感染的一种潜在的新策略提供理论指导，为改善糖尿病患者的生活质量带来新的治疗策略。
Abstract: Diabetic foot ulcer (DFU), a severe complication of diabetes mellitus, presents a significant clinical challenge to public health systems due to their propensity for chronic infection, impaired tissue repair, high amputation rates, and escalating treatment costs. Antimicrobial peptides (AMPs) have emerged as a promising therapeutic strategy, offering multiple antimicrobial mechanisms and a low risk of resistance. Current research indicates that single AMPs, combination therapies, and relevant delivery systems have shown considerable efficacy. However, despite their potential, the specific molecular mechanisms, clinical translation, and long-term safety of AMPs require further in-depth exploration. Future research should prioritize elucidating the molecular mechanisms of AMPs, developing intelligent delivery systems, and conducting large-scale clinical trials to overcome the barriers to clinical translation. This article reviews recent advancements in AMPs and related therapeutic strategies for promoting DFU repair, both domestically and internationally, aiming to provide theoretical guidance for AMPs as a potential novel treatment for DFU infections and to introduce new therapeutic strategies for enhancing the quality of life for diabetic patients.
文章引用：巨翡叶, 聂立波, 覃佐东, 罗小芳. 抗菌肽治疗糖尿病足溃疡的研究进展[J]. 生物医学, 2025, 15(3): 555-563. https://doi.org/10.12677/hjbm.2025.153064

参考文献

[1] Besseling, J., Kastelein, J.J.P., Defesche, J.C., Hutten, B.A. and Hovingh, G.K. (2015) Association between Familial Hypercholesterolemia and Prevalence of Type 2 Diabetes Mellitus. JAMA, 313, 1029-1036. [Google Scholar] [CrossRef] [PubMed]
[2] Jiang, Y., Wang, X., Xia, L., Fu, X., Xu, Z., Ran, X., et al. (2015) A Cohort Study of Diabetic Patients and Diabetic Foot Ulceration Patients in China. Wound Repair and Regeneration, 23, 222-230. [Google Scholar] [CrossRef] [PubMed]
[3] Bandyk, D.F. (2018) The Diabetic Foot: Pathophysiology, Evaluation, and Treatment. Seminars in Vascular Surgery, 31, 43-48. [Google Scholar] [CrossRef] [PubMed]
[4] Everett, E. and Mathioudakis, N. (2018) Update on Management of Diabetic Foot Ulcers. Annals of the New York Academy of Sciences, 1411, 153-165. [Google Scholar] [CrossRef] [PubMed]
[5] Niu, Y., Li, Q., Ding, Y., Dong, L. and Wang, C. (2019) Engineered Delivery Strategies for Enhanced Control of Growth Factor Activities in Wound Healing. Advanced Drug Delivery Reviews, 146, 190-208. [Google Scholar] [CrossRef] [PubMed]
[6] Pirtskhalava, M., Vishnepolsky, B., Grigolava, M. and Managadze, G. (2021) Physicochemical Features and Peculiarities of Interaction of AMP with the Membrane. Pharmaceuticals, 14, Article 471. [Google Scholar] [CrossRef] [PubMed]
[7] Yeaman, M.R. and Yount, N.Y. (2003) Mechanisms of Antimicrobial Peptide Action and Resistance. Pharmacological Reviews, 55, 27-55. [Google Scholar] [CrossRef] [PubMed]
[8] Gao, X., Ding, J., Liao, C., Xu, J., Liu, X. and Lu, W. (2021) Defensins: The Natural Peptide Antibiotic. Advanced Drug Delivery Reviews, 179, Article ID: 114008. [Google Scholar] [CrossRef] [PubMed]
[9] Brady, D., Grapputo, A., Romoli, O. and Sandrelli, F. (2019) Insect Cecropins, Antimicrobial Peptides with Potential Therapeutic Applications. International Journal of Molecular Sciences, 20, Article 5862. [Google Scholar] [CrossRef] [PubMed]
[10] Wei, X., Zhang, L., Yang, Y., Hou, Y., Xu, Y., Wang, Z., et al. (2022) LL-37 Transports Immunoreactive cGAMP to Activate STING Signaling and Enhance Interferon-Mediated Host Antiviral Immunity. Cell Reports, 39, Article ID: 110880. [Google Scholar] [CrossRef] [PubMed]
[11] Fabisiak, A., Murawska, N. and Fichna, J. (2016) LL-37: Cathelicidin-Related Antimicrobial Peptide with Pleiotropic Activity. Pharmacological Reports, 68, 802-808. [Google Scholar] [CrossRef] [PubMed]
[12] Carretero, M., Escámez, M.J., García, M., Duarte, B., Holguín, A., Retamosa, L., et al. (2008) In Vitro and in Vivo Wound Healing-Promoting Activities of Human Cathelicidin LL-37. Journal of Investigative Dermatology, 128, 223-236. [Google Scholar] [CrossRef] [PubMed]
[13] Xi, L., Du, J., Xue, W., Shao, K., Jiang, X., Peng, W., et al. (2024) Cathelicidin LL-37 Promotes Wound Healing in Diabetic Mice by Regulating TFEB-Dependent Autophagy. Peptides, 175, Article ID: 171183. [Google Scholar] [CrossRef] [PubMed]
[14] Gomes, D., Santos, R., S. Soares, R., Reis, S., Carvalho, S., Rego, P., et al. (2020) Pexiganan in Combination with Nisin to Control Polymicrobial Diabetic Foot Infections. Antibiotics, 9, Article 128. [Google Scholar] [CrossRef] [PubMed]
[15] Ferreira Cespedes, G., Nicolas Lorenzon, E., Festozo Vicente, E., Jose Soares Mendes-Giannini, M., Fontes, W., de Souza Castro, M., et al. (2012) Mechanism of Action and Relationship between Structure and Biological Activity of Ctx-Ha: A New Ceratotoxin-Like Peptide from Hypsiboas Albopunctatus. Protein & Peptide Letters, 19, 596-603. [Google Scholar] [CrossRef] [PubMed]
[16] Rai, D.K. and Qian, S. (2017) Interaction of the Antimicrobial Peptide Aurein 1.2 and Charged Lipid Bilayer. Scientific Reports, 7, Article No. 3719. [Google Scholar] [CrossRef] [PubMed]
[17] Yoneyama, F., Imura, Y., Ichimasa, S., Fujita, K., Zendo, T., Nakayama, J., et al. (2009) Lacticin Q, a Lactococcal Bacteriocin, Causes High-Level Membrane Permeability in the Absence of Specific Receptors. Applied and Environmental Microbiology, 75, 538-541. [Google Scholar] [CrossRef] [PubMed]
[18] Jekhmane, S., Derks, M.G.N., Maity, S., Slingerland, C.J., Tehrani, K.H.M.E., Medeiros-Silva, J., et al. (2024) Host Defence Peptide Plectasin Targets Bacterial Cell Wall Precursor Lipid II by a Calcium-Sensitive Supramolecular Mechanism. Nature Microbiology, 9, 1778-1791. [Google Scholar] [CrossRef] [PubMed]
[19] Barbosa, A.A.T., de Melo, M.R., da Silva, C.M.R., Jain, S. and Dolabella, S.S. (2021) Nisin Resistance in Gram-Positive Bacteria and Approaches to Circumvent Resistance for Successful Therapeutic Use. Critical Reviews in Microbiology, 47, 376-385. [Google Scholar] [CrossRef] [PubMed]
[20] Xuan, J., Feng, W., Wang, J., Wang, R., Zhang, B., Bo, L., et al. (2023) Antimicrobial Peptides for Combating Drug-Resistant Bacterial Infections. Drug Resistance Updates, 68, Article ID: 100954. [Google Scholar] [CrossRef] [PubMed]
[21] Li, W., Chen, H., Cai, J., Wang, M., Zhou, X. and Ren, L. (2023) Poly(pentahydropyrimidine)‐Based Hybrid Hydrogel with Synergistic Antibacterial and Pro‐Angiogenic Ability for the Therapy of Diabetic Foot Ulcers. Advanced Functional Materials, 33, Article ID: 2303147. [Google Scholar] [CrossRef] 
[22] Huang, Y., Lin, C., Cheng, N., Cazzell, S.M., Chen, H., Huang, K., et al. (2021) Effect of a Novel Macrophage-Regulating Drug on Wound Healing in Patients with Diabetic Foot Ulcers: A Randomized Clinical Trial. JAMA Network Open, 4, e2122607. [Google Scholar] [CrossRef] [PubMed]
[23] Li, Z., Qu, W., Zhang, D., Sun, Y. and Shang, D. (2023) The Antimicrobial Peptide Chensinin-1b Alleviates the Inflammatory Response by Targeting the TLR4/NF-κB Signaling Pathway and Inhibits Pseudomonas aeruginosa Infection and LPS-Mediated Sepsis. Biomedicine & Pharmacotherapy, 165, Article ID: 115227. [Google Scholar] [CrossRef] [PubMed]
[24] Li, Y., Liu, T., Liu, Y., Tan, Z., Ju, Y., Yang, Y., et al. (2019) Antimicrobial Activity, Membrane Interaction and Stability of the D-Amino Acid Substituted Analogs of Antimicrobial Peptide W3R6. Journal of Photochemistry and Photobiology B: Biology, 200, Article ID: 111645. [Google Scholar] [CrossRef] [PubMed]
[25] Ma, X., Liu, Q., Kuai, L., Ma, X., Luo, Y., Luo, Y., et al. (2023) The Role of Neutrophils in Diabetic Ulcers and Targeting Therapeutic Strategies. International Immunopharmacology, 124, Article ID: 110861. [Google Scholar] [CrossRef] [PubMed]
[26] Yanagisawa, T., Ishii, M., Takahashi, M., Fujishima, K. and Nishimura, M. (2020) Human Cathelicidin Antimicrobial Peptide LL-37 Promotes Lymphangiogenesis in Lymphatic Endothelial Cells through the ERK and Akt Signaling Pathways. Molecular Biology Reports, 47, 6841-6854. [Google Scholar] [CrossRef] [PubMed]
[27] Herman, A. and Herman, A.P. (2023) Antimicrobial Peptides for Diabetic Wound Healing: Preclinical and Clinical Studies. Advances in Wound Care. [Google Scholar] [CrossRef] [PubMed]
[28] Sun, D., Guo, K., Liu, N., Li, Y., Li, Y., Hu, Y., et al. (2023) Peptide RL-QN15 Promotes Wound Healing of Diabetic Foot Ulcers through P38 Mitogen-Activated Protein Kinase and smad3/miR-4482-3p/vascular Endothelial Growth Factor B Axis. Burns & Trauma, 11, tkad035. [Google Scholar] [CrossRef] [PubMed]
[29] Li, F., Zhang, C., Zhong, X., Li, B., Zhang, M., Li, W., et al. (2024) A 3D Radially Aligned Nanofiber Scaffold Co-Loaded with LL37 Mimetic Peptide and PDGF-BB for the Management of Infected Chronic Wounds. Materials Today Bio, 28, Article ID: 101237. [Google Scholar] [CrossRef] [PubMed]
[30] Lipsky, B.A., Holroyd, K.J. and Zasloff, M. (2008) Topical versus Systemic Antimicrobial Therapy for Treating Mildly Infected Diabetic Foot Ulcers: A Randomized, Controlled, Double‐Blinded, Multicenter Trial of Pexiganan Cream. Clinical Infectious Diseases, 47, 1537-1545. [Google Scholar] [CrossRef] [PubMed]
[31] E. Greber, K. and Dawgul, M. (2016) Antimicrobial Peptides Under Clinical Trials. Current Topics in Medicinal Chemistry, 17, 620-628. [Google Scholar] [CrossRef] [PubMed]
[32] Larson, D., Neelon, J., Karna, S.L.R. and Nuutila, K. (2025) Local Treatment of Wound Infections: A Review of Clinical Trials from 2013 to 2024. Advances in Wound Care, 14, 14-32. [Google Scholar] [CrossRef] [PubMed]
[33] Li, H. (2024) Antimicrobial Peptides—A Promising Novel Antimicrobial Agent. Theoretical and Natural Science, 40, 16-21. [Google Scholar] [CrossRef] 
[34] Norahan, M.H., Pedroza-González, S.C., Sánchez-Salazar, M.G., Álvarez, M.M. and Trujillo de Santiago, G. (2023) Structural and Biological Engineering of 3D Hydrogels for Wound Healing. Bioactive Materials, 24, 197-235. [Google Scholar] [CrossRef] [PubMed]
[35] Soliman, B.G., Nguyen, A.K., Gooding, J.J. and Kilian, K.A. (2024) Advancing Synthetic Hydrogels through Nature‐inspired Materials Chemistry. Advanced Materials, 36, e2404235. [Google Scholar] [CrossRef] [PubMed]
[36] Zhou, J., Wang, Z., Yang, C., Zhang, H., Fareed, M.S., He, Y., et al. (2022) A Carrier-Free, Dual-Functional Hydrogel Constructed of Antimicrobial Peptide Jelleine-1 and 8BR-Camp for MRSA Infected Diabetic Wound Healing. Acta Biomaterialia, 151, 223-234. [Google Scholar] [CrossRef] [PubMed]
[37] Wei, S., Xu, P., Yao, Z., Cui, X., Lei, X., Li, L., et al. (2021) A Composite Hydrogel with Co-Delivery of Antimicrobial Peptides and Platelet-Rich Plasma to Enhance Healing of Infected Wounds in Diabetes. Acta Biomaterialia, 124, 205-218. [Google Scholar] [CrossRef] [PubMed]
[38] Li, Z., Chen, L., Yang, S., Han, J., Zheng, Y., Chen, Z., et al. (2024) Glucose and Ph Dual-Responsive Hydrogels with Antibacterial, Reactive Oxygen Species Scavenging, and Angiogenesis Properties for Promoting the Healing of Infected Diabetic Foot Ulcers. Acta Biomaterialia, 190, 205-218. [Google Scholar] [CrossRef] [PubMed]
[39] Jeong, S.H., Cheong, S., Kim, T.Y., Choi, H. and Hahn, S.K. (2023) Supramolecular Hydrogels for Precisely Controlled Antimicrobial Peptide Delivery for Diabetic Wound Healing. ACS Applied Materials & Interfaces, 15, 16471-16481. [Google Scholar] [CrossRef] [PubMed]
[40] Fang, J., Islam, W. and Maeda, H. (2020) Exploiting the Dynamics of the EPR Effect and Strategies to Improve the Therapeutic Effects of Nanomedicines by Using EPR Effect Enhancers. Advanced Drug Delivery Reviews, 157, 142-160. [Google Scholar] [CrossRef] [PubMed]
[41] Huang, F., Lu, X., Yang, Y., Yang, Y., Li, Y., Kuai, L., et al. (2022) Microenvironment‐Based Diabetic Foot Ulcer Nanomedicine. Advanced Science, 10, e2203308. [Google Scholar] [CrossRef] [PubMed]
[42] Ropero-Vega, J.L., Ardila-Rosas, N., Hernández, I.P. and Flórez-Castillo, J.M. (2020) Immobilization of Ib-M2 Peptide on Core@shell Nanostructures Based on SPION Nanoparticles and Their Antibacterial Activity against Escherichia coli O157:h7. Applied Surface Science, 515, Article ID: 146045. [Google Scholar] [CrossRef] 
[43] Kamaraj, M., Moghimi, N., McCarthy, A., Chen, J., Cao, S., Chethikkattuveli Salih, A.R., et al. (2024) Granular Porous Nanofibrous Microspheres Enhance Cellular Infiltration for Diabetic Wound Healing. ACS Nano, 18, 28335-28348. [Google Scholar] [CrossRef] [PubMed]
[44] Wadhwani, P., Heidenreich, N., Podeyn, B., Bürck, J. and Ulrich, A.S. (2017) Antibiotic Gold: Tethering of Antimicrobial Peptides to Gold Nanoparticles Maintains Conformational Flexibility of Peptides and Improves Trypsin Susceptibility. Biomaterials Science, 5, 817-827. [Google Scholar] [CrossRef] [PubMed]
[45] Comune, M., Rai, A., Chereddy, K.K., Pinto, S., Aday, S., Ferreira, A.F., et al. (2017) Antimicrobial Peptide-Gold Nanoscale Therapeutic Formulation with High Skin Regenerative Potential. Journal of Controlled Release, 262, 58-71. [Google Scholar] [CrossRef] [PubMed]
[46] Cheng, H., Shi, Z., Yue, K., Huang, X., Xu, Y., Gao, C., et al. (2021) Sprayable Hydrogel Dressing Accelerates Wound Healing with Combined Reactive Oxygen Species-Scavenging and Antibacterial Abilities. Acta Biomaterialia, 124, 219-232. [Google Scholar] [CrossRef] [PubMed]
[47] John, J.V., Sharma, N.S., Tang, G., Luo, Z., Su, Y., Weihs, S., et al. (2022) Nanofiber Aerogels with Precision Macrochannels and Ll‐37‐Mimic Peptides Synergistically Promote Diabetic Wound Healing. Advanced Functional Materials, 33, Article ID: 2206936. [Google Scholar] [CrossRef] [PubMed]
[48] Yang, H., Lv, D., Qu, S., Xu, H., Li, S., Wang, Z., et al. (2024) A Ros‐Responsive Lipid Nanoparticles Release Multifunctional Hydrogel Based on Microenvironment Regulation Promotes Infected Diabetic Wound Healing. Advanced Science, 11, Article ID: 2403219. [Google Scholar] [CrossRef] [PubMed]
[49] Vicente, A.M., Ballensiefen, W. and Jönsson, J. (2020) How Personalised Medicine Will Transform Healthcare by 2030: The ICPerMed Vision. Journal of Translational Medicine, 18, Article No. 180. [Google Scholar] [CrossRef] [PubMed]

为你推荐